Replies to post #176348 on Biotech Values

[DewDiligence]

NVS/MNTA/MYL file response to USSC (as expected):

http://finance.yahoo.com/news/generics-file-response-teva-copaxone-214820814.html

Novartis AG's Sandoz Inc, Momenta Pharmaceuticals Inc, Mylan Inc and Natco Pharma Ltd were responding to a stay application made by Teva to Chief Justice John Roberts last week. The Supreme Court could now announce at any time whether it will grant the request [effectively the request for an injunction].

… In their joint court filing, the companies said in part that Teva had not shown that it would suffer "irreparable harm" if a stay [of the CAFC ruling] was not issued.